Old Web
English
Sign In
Acemap
>
authorDetail
>
Nina Nordin
Nina Nordin
Karolinska Institutet
Medicine
Physical therapy
Fingolimod
Multiple sclerosis
Cohort
4
Papers
264
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosis
2016
Multiple Sclerosis Journal
Thomas Frisell
L. Forsberg
Nina Nordin
C Kiesel
Lars Alfredsson
Johan Askling
Jan Hillert
Tomas Olsson
Fredrik Piehl
Show All
Source
Cite
Save
Citations (32)
The IMSE 2 study : a Swedish nationwide pharmaco-epidemiological and genetic study focused on long-term safety and efficacy of fingolimod
2015
Multiple Sclerosis Journal
Sverker Johansson
L. Forsberg
Nina Nordin
Jan Hillert
Anders Svenningsson
Jan Lycke
Joachim Burman
Anne-Marie Landtblom
F. Walentin
Claes Martin
Peter Nilsson
Charlotte Dahle
F. Piehl
Tomas Olsson
Show All
Source
Cite
Save
Citations (0)
Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia
2014
Neurology
Clemens Warnke
Thomas Dehmel
Ryan Ramanujam
Carolina Holmén
Nina Nordin
Kathleen Wolfram
Verena I. Leussink
Hans-Peter Hartung
Tomas Olsson
Bernd C. Kieseier
Show All
Source
Cite
Save
Citations (18)
Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis
2011
Brain
Anna Karin Hedström
Emilie Sundqvist
Maria Bäärnhielm
Nina Nordin
Jan Hillert
Ingrid Kockum
Tomas Olsson
Lars Alfredsson
Show All
Source
Cite
Save
Citations (214)
1